| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pacira Biosciences, Inc. (PCRX) has 15 insiders with recent SEC Form 4 filings, including 3 buys and 9 sells. PCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 399.0K | $9.38M | - | |
| Other | 218.9K | $5.15M | - | |
| Other | 167.1K | $3.93M | -10,259 | |
| CFO | 118.3K | $2.78M | - | |
| VP | 62.3K | $1.46M | -6,115 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2016 | Longenecker John P Phd | Director | Buy | 300 | $66.55 | $19,964.70 | +15.0% | |
| Nov 20, 2015 | Hastings Paul J77 | Director | Sale+OE | 3,000 | $60.00 | $180,000.00 | -51.3% | |
| Oct 15, 2015 | Stack David M67 | President, CEO And Chairman | Sale+OE | 15,000 | $37.57 | $563,561.22 | -61.2% | |
| Sep 11, 2015 | Scibetta James S | SVP, Chief Financial Officer | Buy | 5,000 | $61.37 | $306,850.00 | +90.8% | |
| Aug 17, 2015 | Hastings Paul J77 | Director | Sale+OE | 3,000 | $60.02 | $180,060.00 | -51.3% | |
| Jul 15, 2015 | Stack David M67 | President, CEO And Chairman | Sale+OE | 15,000 | $67.78 | $1,016,700.00 | -98.8% | |
| Apr 15, 2015 | Stack David M67 | President, CEO And Chairman | Sale+OE | 25,000 | $90.50 | $2,262,475.00 | -99.8% | |
| Apr 10, 2015 | Hastings Paul J77 | Director | Sale+OE | 2,500 | $88.00 | $220,000.00 | -74.6% | |
| Mar 16, 2015 | Riker Lauren Bullaro76 | Executive Director, Finance | Sale+OE | 5,000 | $95.34 | $476,700.00 | -69.2% | |
| Mar 13, 2015 | Pace Gary W66 | Director | Buy | 1,000 | $93.83 | $93,829.90 | +5.7% |